Company intelligence / Profile preview

Solenic Medical

Addison, Texas, United Statessolenic.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Solenic Medical has developed a patented non-invasive AMF-based device to treat prosthetic joint and other metallic implant infections by disrupting bacterial biofilms. The approach aims to reduce or eliminate the need for revision surgeries. As of early/mid 2025, the company was preparing to expand clinical studies and had demonstrated preclinical and initial clinical feasibility but had not yet reached commercialization.

Therapeutic areas: Infectious Diseases
Modalities: DeviceNon-pharmacological therapy (thermal therapy via alternating magnetic fields)
Industry: Therapeutic Medical Devices

Partnerships

Johnson & Johnson Innovation–JJDC Inc. (investor/partner)

Beyond the preview

Go deeper on Solenic Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solenic Medical.

Explore the full profile